Tango Therapeutics
TNGX
115 hedge funds and large institutions have $652M invested in Tango Therapeutics in 2025 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 42 increasing their positions, 30 reducing their positions, and 28 closing their positions.
1,265% more call options, than puts
Call options by funds: $1.32M | Put options by funds: $97K
342% more capital invested
Capital invested by funds: $147M → $652M (+$504M)
75% more funds holding in top 10
Funds holding in top 10: 4 → 7 (+3)
40% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 30
18.15% more ownership
Funds ownership: 99.24% → 117.39% (+18%)
6% less funds holding
Funds holding: 122 → 115 (-7)
25% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 28
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$14.6M |
| 2 |
WP
Woodline Partners
San Francisco,
California
|
+$13.7M |
| 3 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$11.2M |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$4.95M |
| 5 |
CC
Commodore Capital
New York
|
+$3.71M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BOCH
Blue Owl Capital Holdings
New York
|
-$3.23M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$2.2M |
| 3 |
BCM
Boxer Capital Management
San Diego,
California
|
-$1.51M |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$1.28M |
| 5 |
SB
Samsara BioCapital
Palo Alto,
California
|
-$1.04M |
TNGX Hedge Fund Activity: Q2 2025 in Review
115 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Tango Therapeutics (TNGX) for Q2 2025, worth a combined $652M — up 342% from $147M a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of TNGX and 21 opened new positions — a net loss of 7 holders — while 30 trimmed existing stakes and 42 added.
The largest buyer was Adage Capital Partners, opening a new position worth an estimated $14.6M. The largest seller was Blue Owl Capital Holdings, cutting an estimated $3.23M.
- 115 institutional investors held Tango Therapeutics (TNGX) as of Q2 2025, down from 122 in Q1 2025.
- Funds reported $652M of Tango Therapeutics stock for Q2 2025, up 342% quarter-over-quarter.
- 21 funds opened new Tango Therapeutics positions in Q2 2025 and 28 closed out, a net change of -7 holders.
- The largest Tango Therapeutics buyer in Q2 2025 was Adage Capital Partners, an estimated $14.6M added.
- The largest Tango Therapeutics seller in Q2 2025 was Blue Owl Capital Holdings, an estimated $3.23M sold.
Based on aggregated 13F filings for Q2 2025.